{"filing":{"accession_number":"0001193125-26-275879","cik":"0001439222","ticker":"AGIO","company_name":"AGIOS PHARMACEUTICALS, INC.","form":"8-K","filing_date":"2026-06-18","report_date":null,"primary_document":"d62491d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1439222/000119312526275879/d62491d8k.htm"},"events":[{"id":11839,"run_id":10415,"accession_number":"0001193125-26-275879","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Agios Pharmaceuticals held its Annual Meeting of Stockholders, at which stockholders elected Class I directors (Rahul Ballal, Brian Goff, Cynthia Smith), approved an advisory vote on named executive officer compensation, approved an amendment to the 2023 Stock Incentive Plan increasing the share reserve by 2,000,000 shares, and ratified PricewaterhouseCoopers LLP as independent auditor.","company_name":"AGIOS PHARMACEUTICALS, INC.","ticker":"AGIO","filing_date":"2026-06-18","form":"8-K","submitted_at":null,"items":[{"id":8529,"accession_number":"0001193125-26-275879","item_number":"5.02","item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The disclosure reports stockholder approval of an amendment to the 2023 Stock Incentive Plan that increases the share reserve by 2,000,000 shares available for equity compensation. This is a compensatory arrangement amendment affecting the pool of shares available for director and officer equity grants, which is a core exec_compensation event under Item 5.02(e).","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T20:14:13.829008+00:00","company_name":"","ticker":null,"filing_date":""},{"id":8530,"accession_number":"0001193125-26-275879","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure presents the results of an Annual Meeting of Stockholders, including election of Class I directors (Rahul Ballal, Brian Goff, Cynthia Smith), advisory vote on named executive officer compensation, approval of the 2023 Plan Amendment, and ratification of PricewaterhouseCoopers LLP as independent auditor. The filing directly matches the shareholder_vote_results taxonomy entry, which covers results of votes at annual or special meetings of security holders.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T20:14:13.829008+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":8529,"accession_number":"0001193125-26-275879","item_number":"5.02","item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The disclosure reports stockholder approval of an amendment to the 2023 Stock Incentive Plan that increases the share reserve by 2,000,000 shares available for equity compensation. This is a compensatory arrangement amendment affecting the pool of shares available for director and officer equity grants, which is a core exec_compensation event under Item 5.02(e).","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T20:14:13.829008+00:00","company_name":"AGIOS PHARMACEUTICALS, INC.","ticker":"AGIO","filing_date":"2026-06-18"},{"id":8530,"accession_number":"0001193125-26-275879","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure presents the results of an Annual Meeting of Stockholders, including election of Class I directors (Rahul Ballal, Brian Goff, Cynthia Smith), advisory vote on named executive officer compensation, approval of the 2023 Plan Amendment, and ratification of PricewaterhouseCoopers LLP as independent auditor. The filing directly matches the shareholder_vote_results taxonomy entry, which covers results of votes at annual or special meetings of security holders.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T20:14:13.829008+00:00","company_name":"AGIOS PHARMACEUTICALS, INC.","ticker":"AGIO","filing_date":"2026-06-18"}]}